## MCHP: Microchip Technology Incorporated - XLK: Technology

### Executive Summary

No thesis match: MRS_10 -0.9% below STRENGTH zone (3.0-6.0%); PEG 5.70 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($60.72)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 5
- **Sentiment:** Neutral (Bullish: 1, Bearish: 0)

**1. Oak Harvest Investment Services Makes New $3.38 Million Investment in Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251230T122034 | Bullish | Relevance: 100%
- Oak Harvest Investment Services has acquired a new stake of 52,643 shares in Microchip Technology Incorporated, valued at approximately $3.38 million during the third quarter. This investment comes as Microchip Technology reported strong Q3 earnings, surpassing analyst estimates, and offered positive guidance for Q3 2026. The company currently holds an average analyst rating of "Moderate Buy" with a target price of $76.

**2. Fort Washington Investment Advisors Inc. OH Sells 77,659 Shares of Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251230T120418 | Neutral | Relevance: 100%
- Fort Washington Investment Advisors Inc. OH reduced its stake in Microchip Technology Incorporated (NASDAQ:MCHP) by 12.4%, selling 77,659 shares in Q3, now holding 546,734 shares valued at $35.11 million. Institutional investors own approximately 91.51% of the semiconductor company's stock, which has a consensus "Moderate Buy" rating and an average price target of $76.

**3. How Microchip Technology Incorporated (MCHP) Affects Rotational Strategy Timing**
- Source: Stock Traders Daily | 20251228T185200 | Neutral | Relevance: 100%
- This article analyzes Microchip Technology Incorporated (MCHP) and its impact on rotational strategy timing, indicating a neutral near and mid-term outlook that could moderate a long-term positive bias. It highlights specific trading strategies, including long, momentum breakout, and short positions, along with risk-reward ratios and multi-timeframe signal analysis. The analysis suggests MCHP is testing resistance, with potential for significant downside if it doesn't hold.

**4. Texas Instruments stock today: TXN flat after ReRAM licensing deal as Fed minutes land**
- Source: ts2.tech | 20251231T020852 | Neutral | Relevance: 64%
- Texas Instruments (TXN) shares were little changed following news that Weebit Nano licensed its ReRAM non-volatile memory IP to the chipmaker for embedded processing chips. This deal is significant for automotive and industrial markets that require persistent data storage, sectors where TI is a major player. The muted stock reaction reflects a slow trading day on Wall Street and came as investors digested minutes from the Federal Reserve's December meeting.

**5. Texas Instruments stock dips as Weebit Nano ReRAM license lands â€” what TXN investors watch next**
- Source: ts2.tech | 20251229T135500 | Somewhat-Bearish | Relevance: 60%
- Texas Instruments shares fell 0.8% after Weebit Nano licensed its ReRAM technology to the chipmaker. This deal is significant as chipmakers seek alternatives to embedded flash memory for smaller designs and tougher operating environments, with TI focusing on industrial and automotive applications. Investors are now watching for product integration success in these sectors and TI's upcoming earnings report for demand insights.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Cantor Fitzgera | $85 | $65 | +31% |
| 2025-12-05 | B of A Securiti | $72 | $67 | +7% |
| 2025-12-04 | Needham | $75 | $73 | +3% |
| 2025-12-03 | Rosenblatt | $80 | $80 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Cantor Fitzgera | up | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |
| 2025-12-04 | Needham | main | Buy |
| 2025-12-03 | Rosenblatt | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 11 ($0.27M) |
| Sells | 6 ($9.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.3% (+2.1%)
- Blackrock Inc.: 9.7% (-2.0%)
- State Street Corpora: 5.2% (-11.9%)
- Boston Partners: 3.0% (+9.5%)
- Geode Capital Manage: 2.8% (+2.3%)

### Key Risks

1. Insider selling cluster: $9.3M in recent transactions.
2. Valuation stretched: PEG 5.7x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +14%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 5.70 signals overvaluation risk, limited margin of safety. Forward P/E 25.9x attractive for 72% earnings growth. Balance sheet: strong liquidity (2.2x). Analyst sentiment positive (3 raises, avg +14%). Insider selling cluster ($9.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.0B |
| Beta | 1.46 |
| 52W Range | $34.13 - $77.20 |
| Short Interest | 5.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.70 |
| Forward P/E | 25.9 |
| Current P/E | 44.5 |
| YoY Growth | 71.7% |
| EPS Direction | STABLE |

### Technicals

MRS_10 strengthening from -2.5% to -0.9% (+1.6% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.9pp (needs >3.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.06x) but short-term weakness (below SMA20). RSI neutral at 56. OFD pattern: -SLL (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.93% (CS: 32) | Neutral |
| RSI_14 | 55.8 | Neutral |
| MACD Histogram | -0.29 | Bearish |
| vs SMA20 | 0.990x | Below |
| vs SMA50 | 1.065x | Above |
| vs SMA200 | 1.060x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $64.68
- **Stop Loss:** $60.72 (6.1% risk)
- **Target:** $68.64 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 277
- **Position Value:** $17,916.36
- **Portfolio %:** 17.92%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-05 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +4.9% |
| 2025Q2 | $0.24 | $0.27 | +13.2% |
| 2025Q1 | $0.10 | $0.11 | +5.3% |
| 2024Q4 | $0.28 | $0.20 | -28.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*